CHMP5 and infection: A recent study using an mRNA vaccine based on the Beta variant spike protein found that such design could elicit higher neutralizing antibody titers against Beta variant infection in comparison to the wild-type spike in non-human primates, showing the great potential of mutant spike proteins in designing variant-specific vaccines47.